Logo image of CTIB

YUNHONG CTI LTD (CTIB) Stock Fundamental Analysis

NASDAQ:CTIB - Nasdaq - US98873Q1004 - Common Stock - Currency: USD

2.4  +0.43 (+21.83%)

After market: 2.36 -0.04 (-1.67%)

Fundamental Rating

1

CTIB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 64 industry peers in the Household Durables industry. Both the profitability and financial health of CTIB have multiple concerns. CTIB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CTIB has reported negative net income.
CTIB had a positive operating cash flow in the past year.
In the past 5 years CTIB always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: CTIB reported negative operating cash flow in multiple years.
CTIB Yearly Net Income VS EBIT VS OCF VS FCFCTIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -5M -10M

1.2 Ratios

The profitability ratios for CTIB are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTIB Yearly ROA, ROE, ROICCTIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300

1.3 Margins

CTIB has a Gross Margin of 17.33%. This is amonst the worse of the industry: CTIB underperforms 92.54% of its industry peers.
In the last couple of years the Gross Margin of CTIB has declined.
The Profit Margin and Operating Margin are not available for CTIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.6%
GM growth 5Y-6.59%
CTIB Yearly Profit, Operating, Gross MarginsCTIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

CTIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTIB has been increased compared to 1 year ago.
The debt/assets ratio for CTIB has been reduced compared to a year ago.
CTIB Yearly Shares OutstandingCTIB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
CTIB Yearly Total Debt VS Total AssetsCTIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

CTIB has an Altman-Z score of 1.38. This is a bad value and indicates that CTIB is not financially healthy and even has some risk of bankruptcy.
CTIB's Altman-Z score of 1.38 is on the low side compared to the rest of the industry. CTIB is outperformed by 79.10% of its industry peers.
CTIB has a debt to FCF ratio of 11.30. This is a negative value and a sign of low solvency as CTIB would need 11.30 years to pay back of all of its debts.
CTIB has a Debt to FCF ratio of 11.30. This is in the lower half of the industry: CTIB underperforms 67.16% of its industry peers.
CTIB has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.10, CTIB is not doing good in the industry: 77.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 11.3
Altman-Z 1.38
ROIC/WACCN/A
WACC9.25%
CTIB Yearly LT Debt VS Equity VS FCFCTIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.29 indicates that CTIB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.29, CTIB is doing worse than 88.06% of the companies in the same industry.
A Quick Ratio of 0.41 indicates that CTIB may have some problems paying its short term obligations.
With a Quick ratio value of 0.41, CTIB is not doing good in the industry: 94.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.41
CTIB Yearly Current Assets VS Current LiabilitesCTIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.62% over the past year.
The Revenue for CTIB has decreased by -17.59% in the past year. This is quite bad
The Revenue for CTIB have been decreasing by -20.33% on average. This is quite bad
EPS 1Y (TTM)94.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90%
Revenue 1Y (TTM)-17.59%
Revenue growth 3Y-17.61%
Revenue growth 5Y-20.33%
Sales Q2Q%-8.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTIB Yearly Revenue VS EstimatesCTIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTIB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTIB Price Earnings VS Forward Price EarningsCTIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CTIB is valued a bit more expensive than the industry average as 68.66% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 89.15
EV/EBITDA N/A
CTIB Per share dataCTIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

YUNHONG CTI LTD

NASDAQ:CTIB (9/22/2023, 8:00:01 PM)

After market: 2.36 -0.04 (-1.67%)

2.4

+0.43 (+21.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-03 2023-08-03/bmo
Earnings (Next)N/A N/A
Inst Owners2.18%
Inst Owner Change7.95%
Ins Owners8.57%
Ins Owner Change0%
Market Cap48.23M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.85
P/FCF 89.15
P/OCF 68.51
P/B 12.4
P/tB 12.4
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY1.12%
OCF(TTM)0.04
OCFY1.46%
SpS0.84
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.33%
FCFM 3.19%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.6%
GM growth 5Y-6.59%
F-Score3
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 11.3
Debt/EBITDA N/A
Cap/Depr 48.08%
Cap/Sales 0.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.41
Altman-Z 1.38
F-Score3
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)37.17%
Cap/Depr(5y)31%
Cap/Sales(3y)0.72%
Cap/Sales(5y)0.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.59%
Revenue growth 3Y-17.61%
Revenue growth 5Y-20.33%
Sales Q2Q%-8.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-547.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.59%
FCF growth 3Y-15%
FCF growth 5Y34.02%
OCF growth 1Y-67.25%
OCF growth 3Y-13.59%
OCF growth 5Y13.45%